Perikabiven NDC 63323-714

NDC codes

FDA NDC Directory

Product NDC (as listed)63323-714Labeler and product segments. Claims need a package NDC.

Product NDC at billing width63323-0714Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package	Copy
63323-714-14	63323071414	1440 mL in 1 BAG (63323-714-14)Marketed from Aug 25, 2014
63323-714-19	63323071419	1920 mL in 1 BAG (63323-714-19)Marketed from Aug 25, 2014

How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): Perikabiven
Generic name (nonproprietary): dextrose, soybean oil, electrolytes, lysine, phenylalanine, leucine, valine, threonine, methionine, isoleucine, tryptophan, alanine, arginine, glycine, proline, histidine, glutamic acid, serine, aspartic acid and tyrosine
Active ingredients: Dextrose monohydrate — 7.5 g/100mLSoybean oil — 3.5 g/100mLSodium acetate — 170 mg/100mLPotassium chloride — 124 mg/100mLSodium glycerophosphate anhydrous — 105 mg/100mLMagnesium sulfate heptahydrate — 68 mg/100mLCalcium chloride — 20 mg/100mLLysine hydrochloride — 187 mg/100mLPhenylalanine — 164 mg/100mLLeucine — 164 mg/100mLValine — 152 mg/100mLHistidine — 141 mg/100mLThreonine — 116 mg/100mLMethionine — 116 mg/100mLIsoleucine — 116 mg/100mLTryptophan — 40 mg/100mLAlanine — 333 mg/100mLArginine — 235 mg/100mLGlycine — 164 mg/100mLProline — 141 mg/100mLGlutamic acid — 116 mg/100mLSerine — 94 mg/100mLAspartic acid — 71 mg/100mLTyrosine — 4.8 mg/100mL
Dosage form: Injection, Emulsion
Route: Intravenous
Labeler: Fresenius Kabi USA, LLC
Product type: Prescription drug
Marketing category: NDA — New Drug ApplicationApplication NDA 200656
Marketing start: Aug 25, 2014
Listing expires: Dec 31, 2026
Other FDA classes: Amino Acids (Chemical structure)Calcium (Chemical structure)Divalent (Chemical structure)Increased Coagulation Factor Activity (Physiologic effect)Increased Large Intestinal Motility (Physiologic effect)Increased Large Intestinal Motility (Physiologic effect)Increased Large Intestinal Motility (Physiologic effect)Increased Large Intestinal Motility (Physiologic effect)Inhibition Large Intestine Fluid/Electrolyte Absorption (Physiologic effect)Inhibition Large Intestine Fluid/Electrolyte Absorption (Physiologic effect)Inhibition Large Intestine Fluid/Electrolyte Absorption (Physiologic effect)Inhibition Large Intestine Fluid/Electrolyte Absorption (Physiologic effect)Inhibition Small Intestine Fluid/Electrolyte Absorption (Physiologic effect)Lipids (Chemical structure)Magnesium Ion Exchange Activity (Mechanism)Osmotic Activity (Mechanism)Osmotic Activity (Mechanism)Osmotic Activity (Mechanism)Osmotic Activity (Mechanism)Phosphate Chelating Activity (Mechanism)Potassium Compounds (Chemical structure)Stimulation Large Intestine Fluid/Electrolyte Secretion (Physiologic effect)
Identifiers: Product ID 63323-714_40a5c387-1b0a-4e8e-94e1-f045d7281b0bSPL ID 40a5c387-1b0a-4e8e-94e1-f045d7281b0bSPL set ID c2eb5522-8572-45f4-869d-42f9fd251bb6UNII LX22YL083G, 241ATL177A, 4550K0SC9B, 660YQ98I10, YP1H63LJ2K, SK47B8698T, M4I0D6VV5M, JNJ23Q2COM, 47E5O17Y3R, GMW67QNF9C, HG18B9YRS7, 4QD397987E, 2ZD004190S, AE28F7PNPL, 04Y7590D77, 8DUH1N11BX, OF5P57N2ZX, 94ZLA3W45F, TE7660XO1C, 9DLQ4CIU6V, 3KX376GY7L, 452VLY9402, 30KYC7MIAI, 42HK56048UUPC 0363323714192, 0363323714147
Pharmacologic class: Amino Acid; Blood Coagulation Factor; Calculi Dissolution Agent; Lipid Emulsion; Osmotic Laxative; Phosphate Binder; Potassium Salt

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No drug-specific HCPCS code in Med-Code's directory for this product. The directory is curated and not complete — check the current CMS HCPCS file before billing.

Administration

Drug administration (CPT 96360–96549)

When a clinician administers the drug, the administration is reported separately. Codes in this range cover hydration, therapeutic injections and infusions, and chemotherapy or other complex drug administration. The right code depends on route, duration and drug type, and self-administered drugs are not billed this way.

How CPT relates to drug billing

NDC on a medical claim

N463323071414 followed by a unit qualifier and the quantity

Package 63323-0714-14. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective Sep 15, 2025.

Indications (excerpt from the label)

PERIKABIVEN is indicated as a source of calories, protein, electrolytes and essential fatty acids for adult patients requiring parenteral nutrition when oral or enteral nutrition is not possible, insufficient, or contraindicated. PERIKABIVEN may be used to prevent essential fatty acid deficiency or treat negative nitrogen balance in adult patients. PERIKABIVEN is indicated as a source of calories, protein, electrolytes and essential fatty acids for adult patients requiring parenteral nutrition when oral or enteral nutrition is not possible, insufficient, or contraindicated. PERIKABIVEN may be used to prevent essential fatty acid deficiency or treat negative nitrogen balance in adult patients…

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)

Other NDCs under NDA 200656

Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.

FDA NDC Directory listings under NDA 200656
Product	Strength	Form · route	Labeler	Product NDC
Kabivendextrose, soybean oil, electrolytes, lysine, phenylalanine, leucine, valine, threonine, methionine, isoleucine, tryptophan, alanine, arginine, glycine, proline, histidine, glutamic acid, serine, aspartic acid and tyrosine	Dextrose monohydrate 10.8 g/100mL + 23 more ingredients	Injection, EmulsionIntravenous	Fresenius Kabi USA, LLC	63323-712